$AKBA Akebia Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Akebia Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Akebia Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Akebia Therapeutics, Inc. for free.
IRS Number: 208756903
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AKBA
Company Address: 245 FIRST STREET CAMBRIDGE 02142
Phone number: 513-985-1920
Market Capitalization: $177.33M
Prev close: $9.88
Average Daily Volume: 251,847
Days Low: $9.60
Year Low: $7.00
Year High: $11.07
Akebia Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2021 | AKBA | Akebia Therapeutic ... | ADAMS ADRIAN | Option Exercise | A | 3.37 | 20,100 | 67,737 | 20,100 | ||
| Jun 03 2021 | AKBA | Akebia Therapeutic ... | ADAMS ADRIAN | Grant | A | 0.00 | 13,700 | 0 | 91,100 | 77.4 K to 91.1 K (+17.70 %) | |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | SVP, CCO | Sell | S | 3.40 | 952 | 3,237 | 137,025 | 138 K to 137 K (-0.69 %) |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Spellman David A | SVP, CFO and Treasu ... | Sell | S | 3.40 | 790 | 2,686 | 76,802 | 77.6 K to 76.8 K (-1.02 %) |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Sell | S | 3.40 | 1,060 | 3,604 | 272,303 | 273.4 K to 272.3 K (-0.39 %) |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Sell | S | 3.40 | 1,211 | 4,117 | 265,550 | 266.8 K to 265.6 K (-0.45 %) |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Sell | S | 3.40 | 4,109 | 13,971 | 1,152,153 | 1.2 M to 1.2 M (-0.36 %) |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Sell | S | 3.40 | 1,081 | 3,675 | 170,761 | 171.8 K to 170.8 K (-0.63 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Spellman David A | SVP, CFO and Treasu ... | Grant | A | 0.00 | 7,592 | 0 | 77,592 | 70 K to 77.6 K (+10.85 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Grant | A | 0.00 | 9,152 | 0 | 137,977 | 128.8 K to 138 K (+7.10 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Grant | A | 0.00 | 10,192 | 0 | 273,363 | 263.2 K to 273.4 K (+3.87 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Grant | A | 0.00 | 11,648 | 0 | 266,761 | 255.1 K to 266.8 K (+4.57 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 39,520 | 0 | 1,156,262 | 1.1 M to 1.2 M (+3.54 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Grant | A | 0.00 | 10,400 | 0 | 171,842 | 161.4 K to 171.8 K (+6.44 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Option Exercise | A | 3.46 | 110,000 | 380,600 | 110,000 |